Australia Life Sciences Market

Save this PDF as:
 WORD  PNG  TXT  JPG

Size: px
Start display at page:

Download "Australia Life Sciences Market"

Transcription

1 Australia Life Sciences Market Monique Roos, Commercial Specialist U.S. Commercial Service, Sydney, Australia November 2014

2 Geographical Size

3 Population Density More than 80% of population in this ring

4 Basic Facts Population 23 million World s 12 th largest economy stable political environment & strong economy 23 years of economic growth forecast GDP growth rate 2014: 3% unemployment: 6.0% Relatively strong Australian Dollar but has fallen 11% in the last year exchange rate: AUD1.00 = USD0.87

5 Economic Drivers Located in the world s fastest growing economy region 4 th largest economy in the Asia Pacific region Reliance on mineral and commodity exports

6 U.S.-Australia Trade Relationship U.S./Australia Free Trade Agreement since 2005 January 2015 marks 10 th anniversary of the FTA Our 12 th largest export market Australia buys more goods from the U.S. than from any other country Major Australian trading partners: China, U.S., Japan

7 Australia s Life Sciences Industry Healthcare System Overview Hospitals Health Trends Regulatory Requirements Medical Eq. Pharmaceuticals Complementary Medicines Dental Eq. Biotechnology Health IT Veterinary Eq. Opportunities

8 Healthcare System Overview Mix of public and private sector funding complex mix of public/private reimbursement Government-funded healthcare scheme approx. 50% of Australians have private health insurance Government primary purchaser of medical products 70% of sales to the Public/Government sector 30% of sales to the Private sector Costs of maintaining a public healthcare system is a concern hospital administrators directed to choose the best product available at the lowest cost

9 Healthcare System (cont d) 9.5% of GDP spent on health comparable to United Kingdom, Spain & Greece vs U.S. (17%) High per capita income demand for full range of sophisticated medical equipment Educated population expectation of state-of-the-art treatment

10 Hospitals 750 public; 590 private Public hospitals large, more complex care intensive care, emergency, major surgery, organ transplants, renal dialysis and specialist outpatient clinics Private hospitals less complex non-emergency care 67% of admissions involving elective surgery shift and now providing more complex services e.g. intensive care, cardiac & oncology units

11 Health Trends Life expectancy is among the highest in the world 80 yrs men; 84 yrs women Leading causes of death include cancer and circulatory system diseases such as heart disease 2012: 63% of adult Australians were overweight or obese Obesity s growing prevalence foreshadows increases in the occurrence of chronic conditions such as diabetes, asthma, and higher healthcare costs

12 Regulatory Requirements Therapeutic Goods Administration (TGA) Regulation of medical devices based on the Global Harmonization Task Force (GHTF) model and closely aligned with the European Union (EU) system for medical devices no recognition of FDA product approvals firms should obtain CE Mark prior to exporting to Australia Australian Sponsor applies for TGA approval and listing of product on the Australian Register of Therapeutic Goods (ARTG)

13 Medical Eq. Ninth-largest export market for U.S. medical products more than 95% of medical devices are imported approx. 60% of these products are from the U.S. other main sources include Germany & Ireland Mature market for medical products sophisticated, competitive & price-sensitive new to market companies may experience strong competition from other U.S. companies or multinationals already in the market

14 Pharmaceuticals One of the top areas of business investment in Australian R&D Australia often chosen by global medicines industry to conduct clinical trials industry is the largest high-technology exporter Pharmaceutical Benefits Scheme (PBS) patients pay $32.00 or $6.00 for concession card holders Federal Govt. subsidizes remaining cost listing involves a rigorous clinical and cost-effectiveness evaluation against already available alternatives Most prescribed medicines broadly reflects the burden of disease in Australia cardiovascular, glaucoma, cancer, respiratory disorders, mental illness, auto immune disorders, high blood pressure, cholesterol

15 Complementary Medicines Complementary Medicines vitamin, mineral, plant or herbal, naturopathic and/or homeopathic preparations some aromatherapy preparations, and nutritional supplements Sophisticated and competitive market 254 complementary medicine companies and 59 manufacturing facilities Australian firms export to more than 20 countries 10,000 complementary medicines on the market 1,800 new complementary medicines listed on the ARTG each year Ageing population a move towards pro-active healthcare & preventative therapy growing popularity of integrated medicines where East meets West. growth categories: provide scientific evidence to support efficacy; products aimed at the ageing baby boomer market; products that help people maintain their health

16 Complementary Medicines Regulation Regulated as medicines evidence of pharmaceutical GMP Lower risk medicines Listed on the ARTG (Aust L) Assessed for quality and safety but not efficacy Only contain low risk, pre-approved ingredients Not make any indications (therapeutic use) for the treatment of a disease or condition Sponsor must certify they hold evidence to support indication and claims High risk medicines Registered on the ARTG (Aust R) Assessed for quality, safety & efficacy

17 Dental Eq. Dependent on imported products market is mature, sophisticated and competitive strong demand for full range of innovative products local manufacturing < than 3% of dental products sold United States is second-largest supplier after Germany Opportunities state of-the-art dental technology; products for ageing population; and cosmetic & preventative procedures

18 Biotechnology Approx. 420 biotechnology companies agricultural biotechnology, biomedicines, biopharmaceuticals, stem cell sciences, environmental biotechnology and diagnostics biomedical strongest sub-sector with well established focus on therapeutics, diagnostics & vaccines world-class science and medical research, & capacity for international partnerships Scientific American Worldview Scorecard 2014 ranks Australia as number four in the world for biotechnology innovation measures countries biotech performance according to productivity, intellectual property protection, intensity, enterprise support, education/workforce, foundations, and policy and stability Emerging trends foodtech and cleantech

19 Health IT Government s National E-Health Strategy National E-Health Transition Authority (NEHTA) - personally controlled electronic health records (PCEHR) 2012 Pursuing solutions to grow a sustainable healthcare system improve health outcomes and respond to increasing cost & demand pressures; greater demand for personalized care; and an ageing population health system serves urban centers, remote and rural areas, and indigenous communities across a vast geographic region solutions need to be integrated and interoperable with the current architecture

20 Veterinary Eq. Sophisticated market for animal health products More than 66% of Australians own pets APVMA - Australian Pesticides and Veterinary Medicines Authority (APVMA): Veterinary chemicals: prevent, diagnose, cure or alleviate a disease, condition cure or alleviate an injury; modify the physiology incl. vitamins, minerals and additives if they are used for above AQIS Australian Quarantine and Inspection Service Import permit required for: Animal Feed - including pet food & treats, stock feed, aquaculture feed, and bait Veterinary Products - such as therapeutics and medicines

21 Opportunities Technology & Products: significantly improve clinical outcomes and/or reduce costs serve an ageing population high level of uptake of innovative technology Many clinicians have spent time in the U.S. Australia s chronic disease burden is similar to the U.S.: asthma, cancer (incl. lung, colorectal), type 2 diabetes, coronary heart disease, stroke, arthritis, osteoporosis, depression, chronic obstructive pulmonary disease (COPD), chronic kidney disease, oral disease Continuing need for high quality & innovative medical equipment and products innovative and high-quality U.S. products are well-received

22 Contact Us U.S. Commercial Service Level 59 MLC Centre, Martin Place Sydney NSW 2000 Australia Tel:

Health care in Australia

Health care in Australia Health care in Australia Stephen R. Leeder MD Professor of Public Health and Community Medicine Director The Menzies Centre for Health Policy The University of Sydney March 26th 2012 Australia at a glance

More information

Australia s primary health care system: Focussing on prevention & management of disease

Australia s primary health care system: Focussing on prevention & management of disease Australia s primary health care system: Focussing on prevention & management of disease Lou Andreatta PSM Assistant Secretary, Primary Care Financing Branch Australian Department of Health and Ageing Recife,

More information

Regulatory requirements for Australia: Medicines, Cosmetics, Household Cleaning and Food Products RFA 2014

Regulatory requirements for Australia: Medicines, Cosmetics, Household Cleaning and Food Products RFA 2014 Regulatory requirements for Australia: Medicines, Cosmetics, Household Cleaning and Food Products Overview Regulation of medicines in Australia Regulation of cosmetic and household products in Australia

More information

NC General Statutes - Chapter 130A Article 7 1

NC General Statutes - Chapter 130A Article 7 1 Article 7. Chronic Disease. Part 1. Cancer. 130A-205. Administration of program; rules. (a) The Department shall establish and administer a program for the prevention and detection of cancer and the care

More information

Healthcare, Regulatory and Reimbursement Landscape - Australia

Healthcare, Regulatory and Reimbursement Landscape - Australia Brochure More information from http://www.researchandmarkets.com/reports/2207850/ Healthcare, Regulatory and Reimbursement Landscape - Australia Description: Healthcare, Regulatory and Reimbursement Landscape

More information

Electronic Medical Record Access Outweighs Privacy Concerns for Chronic Patients in Norway

Electronic Medical Record Access Outweighs Privacy Concerns for Chronic Patients in Norway Insight Driven Health Electronic Medical Record Access Outweighs Privacy Concerns for Chronic Patients in Norway Accenture research shows persons with chronic conditions in Norway are more concerned about

More information

UK Patients with Chronic Conditions Believe the Ability to Access Electronic Medical Records Outweighs Concern of Privacy Invasion

UK Patients with Chronic Conditions Believe the Ability to Access Electronic Medical Records Outweighs Concern of Privacy Invasion Insight Driven Health UK Patients with Chronic Conditions Believe the Ability to Access Electronic Medical Records Outweighs Concern of Privacy Invasion Accenture s research shows patients with chronic

More information

HEALTH CARE COSTS 11

HEALTH CARE COSTS 11 2 Health Care Costs Chronic health problems account for a substantial part of health care costs. Annually, three diseases, cardiovascular disease (including stroke), cancer, and diabetes, make up about

More information

SWECARE FOUNDATION. Uniting the Swedish health care sector for increased international competitiveness

SWECARE FOUNDATION. Uniting the Swedish health care sector for increased international competitiveness SWECARE FOUNDATION Uniting the Swedish health care sector for increased international competitiveness SWEDEN IN BRIEF Population: approx. 9 800 000 (2015) GDP/capita: approx. EUR 43 300 (2015) Unemployment

More information

A Future for the Complementary Medicines Industry

A Future for the Complementary Medicines Industry A Future for the Complementary Medicines Industry The Complementary Healthcare Council continues to advocate for an overarching Complementary Medicine Industry Framework that brings together innovation,

More information

Chronic Disease and Nursing:

Chronic Disease and Nursing: Chronic Disease and Nursing: A Summary of the Issues What s the issue? Chronic diseases are now the major global disease problem facing the world and a key barrier to development, to alleviating poverty,

More information

Technical Supplement OCTOBER 2015

Technical Supplement OCTOBER 2015 Technical Supplement OCTOBER 215 Business Council of October 215 1 Like all first world countries, s population is ageing s population totals 23.9 million people today, and is projected to reach 39.7 million

More information

NHS outcomes framework and CCG outcomes indicators: Data availability table

NHS outcomes framework and CCG outcomes indicators: Data availability table NHS outcomes framework and CCG outcomes indicators: Data availability table December 2012 NHS OF objectives Preventing people from dying prematurely DOMAIN 1: preventing people from dying prematurely Potential

More information

Southern Grampians & Glenelg Shires COMMUNITY PROFILE

Southern Grampians & Glenelg Shires COMMUNITY PROFILE Southern Grampians & Glenelg Shires COMMUNITY PROFILE Contents: 1. Health Status 2. Health Behaviours 3. Public Health Issues 4. References This information was last updated on 14 February 2007 1. Health

More information

Healthy California 2020 Initiative: Consensus Building on Top Priority Areas for CDPH

Healthy California 2020 Initiative: Consensus Building on Top Priority Areas for CDPH Healthy California 2020 Initiative: Consensus Building on Top Priority Areas for CDPH Public Health Advisory Committee April 30, 2010 Introducing the CDPH Decision Framework Responding to public health

More information

New York Bio Conference 2016. Mark J. Alles Chief Executive Officer

New York Bio Conference 2016. Mark J. Alles Chief Executive Officer New York Bio Conference 2016 Mark J. Alles Chief Executive Officer Great Progress AGE 72 World Life Expectancy 2005-2014* 17 new drugs for rare diseases 71.5 71 Two new MS drugs First drug to target root

More information

Population Health Management Program

Population Health Management Program Population Health Management Program Program (formerly Disease Management) is dedicated to improving our members health and quality of life. Our Population Health Management Programs aim to improve care

More information

Submission to the Senate Standing Committee on Economics Inquiry into Australia s Innovation System. Complementary Medicines Australia

Submission to the Senate Standing Committee on Economics Inquiry into Australia s Innovation System. Complementary Medicines Australia Submission to the Senate Standing Committee on Economics Inquiry into Australia s Innovation System By To: Senate Standing Committees on Economics PO Box 6100 Parliament House Canberra ACT 2600 economics.sen@aph.gov.au

More information

Exploring healthcare variation in Australia

Exploring healthcare variation in Australia Exploring healthcare variation in Australia Luke Slawomirski Program Manager, Implementation Support Visiting Fellow, University of Technology Sydney Sep 18, 2014 Outline 1. Australia and its healthcare

More information

Limited Pay Policy (L-222B) - Underwriting Guidelines

Limited Pay Policy (L-222B) - Underwriting Guidelines Limited Pay Policy (L-222B) - Underwriting Guidelines 1 Addiction/Abuser Drug - Past or Present Presently Recovered - AA for last 2 years 2 Aids 3 Alcoholic Presently Recovered - AA for last 2 years 4

More information

Medical Matters Action Checklists

Medical Matters Action Checklists Medical Matters Action Checklists The following Action Checklists are included in Chapter 5: Medical History Personal Medication Record Health Care Power of Attorney Medical Orders (Do Not Resuscitate/POLST)

More information

The largest clinical study of Bayer's Xarelto (rivaroxaban) Wednesday, 14 November 2012 07:38

The largest clinical study of Bayer's Xarelto (rivaroxaban) Wednesday, 14 November 2012 07:38 Bayer HealthCare has announced the initiation of the COMPASS study, the largest clinical study of its oral anticoagulant Xarelto (rivaroxaban) to date, investigating the prevention of major adverse cardiac

More information

Consultative Meeting Regulation of Homeopathic Drugs

Consultative Meeting Regulation of Homeopathic Drugs Republic of the Philippines Department of Health Food and Drug Administration Consultative Meeting Regulation of Homeopathic Drugs FDA Conference Room, 2F, Main Building 24 March 2014 9:00am-12:00nn 1

More information

Location for Trials- Global Considerations A Pharma Perspective. Carlo Maccarrone Assoc. Director, Clinical Research GSK Australia 7 May 2014

Location for Trials- Global Considerations A Pharma Perspective. Carlo Maccarrone Assoc. Director, Clinical Research GSK Australia 7 May 2014 Location for Trials- Global Considerations A Pharma Perspective Carlo Maccarrone Assoc. Director, Clinical Research GSK Australia 7 May 2014 Why Choose Australia for Clinical Trials? What is he saying

More information

Health at a Glance: Europe 2014

Health at a Glance: Europe 2014 Health at a Glance: Europe 2014 (joint publication of the OECD and the European Commission) Released on December 3, 2014 http://www.oecd.org/health/health-at-a-glance-europe-23056088.htm Table of Contents

More information

Submission by the Irish Pharmacy Union to the Department of Health on the Scope for Private Health Insurance to incorporate Additional Primary Care

Submission by the Irish Pharmacy Union to the Department of Health on the Scope for Private Health Insurance to incorporate Additional Primary Care Submission by the Irish Pharmacy Union to the Department of Health on the Scope for Private Health Insurance to incorporate Additional Primary Care Services January 2015 1 IPU Submission to the Department

More information

MERCÈ ROVIRA. How the European Institute for women s health supports health issues at an EU level

MERCÈ ROVIRA. How the European Institute for women s health supports health issues at an EU level MERCÈ ROVIRA How the European Institute for women s health supports health issues at an EU level Supporting women s health issues at the EU-level M. Mercè Rovira Regàs Board Member European Institute of

More information

Evidence-Based Practice for Public Health Identified Knowledge Domains of Public Health

Evidence-Based Practice for Public Health Identified Knowledge Domains of Public Health 1 Biostatistics Statistical Methods & Theory Evidence-Based Practice for Public Health Identified Knowledge Domains of Public Health General Public Health Epidemiology Risk Assessment Population-Based

More information

Inviting Possibilities. Healthcare. Cover Page- Healthcare Sector Report.indd 1

Inviting Possibilities. Healthcare. Cover Page- Healthcare Sector Report.indd 1 Inviting Possibilities Healthcare Cover Page- Healthcare Sector Report.indd 1 7/30/13 1:4 PM TABLE OF CONTENTS Overview of Dubai's Healthcare Industry Investment opportunities Medical research and development

More information

The benefits of prevention: healthy eating and active living

The benefits of prevention: healthy eating and active living The benefits of prevention: healthy eating and active living A Summary of Findings By increasing the proportion of the NSW population who are a healthy weight by 2018 (so that one in two adults are of

More information

Butler Memorial Hospital Community Health Needs Assessment 2013

Butler Memorial Hospital Community Health Needs Assessment 2013 Butler Memorial Hospital Community Health Needs Assessment 2013 Butler County best represents the community that Butler Memorial Hospital serves. Butler Memorial Hospital (BMH) has conducted community

More information

information CIRCULAR Coronary heart disease in Queensland Michael Coory, Health Information Centre, Information & Business Management Branch Summary

information CIRCULAR Coronary heart disease in Queensland Michael Coory, Health Information Centre, Information & Business Management Branch Summary 21 Queensland Government Queensland Health Health Information Centre information CIRCULAR Coronary heart disease in Queensland Michael Coory, Health Information Centre, Information & Business Management

More information

HEDIS/CAHPS 101. August 13, 2012 Minnesota Measurement and Reporting Workgroup

HEDIS/CAHPS 101. August 13, 2012 Minnesota Measurement and Reporting Workgroup HEDIS/CAHPS 101 Minnesota Measurement and Reporting Workgroup Objectives Provide introduction to NCQA Identify HEDIS/CAHPS basics Discuss various components related to HEDIS/CAHPS usage, including State

More information

Analysis of Healthcare IT Spending in Australia

Analysis of Healthcare IT Spending in Australia Analysis of Healthcare IT Spending in Australia An Already Sophisticated Market is Driving Innovation by Vendors 9AB9-48 March 2015 Contents Section Slide Number Executive Summary 3 Healthcare Industry

More information

UnitedHealthcare Choice Plus. United HealthCare Insurance Company. Certificate of Coverage

UnitedHealthcare Choice Plus. United HealthCare Insurance Company. Certificate of Coverage UnitedHealthcare Choice Plus United HealthCare Insurance Company Certificate of Coverage For Westminster College Enrolling Group Number: 715916 Effective Date: January 1, 2009 Offered and Underwritten

More information

Oxford Condition Management Programs: Helping your employees learn, be encouraged and get support

Oxford Condition Management Programs: Helping your employees learn, be encouraged and get support Oxford Condition Management Programs: Helping your employees learn, be encouraged and get support UnitedHealthcare is committed to helping improve the health and well-being of the individuals we serve

More information

Prognosis for Healthcare: The Future of Medicine

Prognosis for Healthcare: The Future of Medicine Prognosis for Healthcare: The Future of Medicine Bruce M. Cohen, M.D., Ph.D. Director, Frazier Research Institute, McLean Hospital President and Psychiatrist in Chief Emeritus, McLean Hospital Robertson-Steele

More information

Introduction. The Healthcare Sector in Asia - Current Situation. Projected Healthcare Expenditure

Introduction. The Healthcare Sector in Asia - Current Situation. Projected Healthcare Expenditure Policy Issues in the Economics and Financing of Medical Technology in the Asia-Pacific Region Dr KAI HONG PHUA Joint Professor Yong Loo Lin School of Medicine and Lee Kuan Yew School of Public Policy National

More information

The European regulatory system for medicines and the European Medicines Agency

The European regulatory system for medicines and the European Medicines Agency The European regulatory system for medicines and the European Medicines Agency A consistent approach to medicines regulation across the European Union An agency of the European Union This booklet is intended

More information

The Australian Healthcare System

The Australian Healthcare System The Australian Healthcare System Professor Richard Osborne, BSc, PhD Chair of Public Health Deakin University Research that informs this presentation Chronic disease self-management Evaluation methods

More information

With the support of COMPLEMENTARY MEDICINE: 3 VITAL INVESTMENT PRIORITIES

With the support of COMPLEMENTARY MEDICINE: 3 VITAL INVESTMENT PRIORITIES With the support of COMPLEMENTARY MEDICINE: 3 VITAL INVESTMENT PRIORITIES Preface The National Institute of Complementary Medicine is seeking to leverage government, industry and community support for

More information

CRITICAL SKILLS FOR OPTIMUM PATIENT CARE: Care Coordination and Health Literacy

CRITICAL SKILLS FOR OPTIMUM PATIENT CARE: Care Coordination and Health Literacy Thursday, August 20, 2015 CRITICAL SKILLS FOR OPTIMUM PATIENT CARE: Care Coordination and Health Literacy Contributors to the Presentation: Steven A. Estrine, PhD, President & CEO Loan Mai, PhD, Director

More information

Ask Us About Clinical Trials

Ask Us About Clinical Trials Ask Us About Clinical Trials Clinical Trials and You. Our specialists and researchers are at the forefront of their fields and are leading the way in developing new therapies and procedures for diagnosing

More information

How companies leverage quality and quality certifications to achieve competitive advantage

How companies leverage quality and quality certifications to achieve competitive advantage How companies leverage quality and quality certifications to achieve competitive advantage Eize de Boer Systems & Services Certification International Business Development Manager Pharma Supply Chain for

More information

Alternative Benefit Plan (ABP) ABP Cost-Sharing & Comparison to Standard Medicaid Services

Alternative Benefit Plan (ABP) ABP Cost-Sharing & Comparison to Standard Medicaid Services Alternative Benefit Plan (ABP) ABP Cost-Sharing & Comparison to Standard Medicaid Services Most adults who qualify for the Medicaid category known as the Other Adult Group receive services under the New

More information

TRANSATLANTIC TRADE AND INVESTMENT PARTNERSHIP

TRANSATLANTIC TRADE AND INVESTMENT PARTNERSHIP DISCLAIMER: The EU reserves the right to make subsequent modifications to this text and to complement its proposals at a later stage, by modifying, supplementing or withdrawing all, or any part, at any

More information

HEALTH INSURANCE EMPLOYEE EDUCATION: PREVENTIVE CARE

HEALTH INSURANCE EMPLOYEE EDUCATION: PREVENTIVE CARE HEALTH INSURANCE EMPLOYEE EDUCATION: PREVENTIVE CARE Mott Community College Health Benefits Task Force DISCLAIMER The content in this presentation is informational. Each employee should review the benefit

More information

RAW PREVALENCE FOR NORTHERN IRELAND AS AT 31 MARCH 2014

RAW PREVALENCE FOR NORTHERN IRELAND AS AT 31 MARCH 2014 1. 2. RAW PREVALENCE FOR NORTHERN IRELAND AS AT 31 MARCH 214 3.1 Coronary Heart Disease (CHD) 3.2 Heart Failure 1 3.3 Heart Failure 3 (heart failure due to Left Ventricular Systolic Dysfunction) 3.4 Stroke

More information

Facts and Figures. The World Health Report 2003 Shaping the Future. Life expectancy

Facts and Figures. The World Health Report 2003 Shaping the Future. Life expectancy World Health Organization Facts and Figures The World Health Report 2003 Shaping the Future Life expectancy Life expectancy at birth in 2002 reached a global average of 65.2 years, compared with 46.5 years

More information

GRADUATE CERTIFICATE IN GOOD MANUFACTURING PRACTICE (GMP) Plan your career for tomorrow and you will be ahead of your competitors

GRADUATE CERTIFICATE IN GOOD MANUFACTURING PRACTICE (GMP) Plan your career for tomorrow and you will be ahead of your competitors GRADUATE CERTIFICATE IN GOOD MANUFACTURING PRACTICE (GMP) Plan your career for tomorrow and you will be ahead of your competitors This course is a distance-learning program that will culminate in a Graduate

More information

Bayer Pharma AG 13342 Berlin Germany Tel. +49 30 468-1111 www.bayerpharma.com. News Release. Not intended for U.S. and UK Media

Bayer Pharma AG 13342 Berlin Germany Tel. +49 30 468-1111 www.bayerpharma.com. News Release. Not intended for U.S. and UK Media News Release Not intended for U.S. and UK Media Bayer Pharma AG 13342 Berlin Germany Tel. +49 30 468-1111 www.bayerpharma.com Bayer Forms Collaboration with Academic and Governmental Institutions for Rivaroxaban

More information

ECONOMIC COSTS OF PHYSICAL INACTIVITY

ECONOMIC COSTS OF PHYSICAL INACTIVITY ECONOMIC COSTS OF PHYSICAL INACTIVITY This fact sheet highlights the prevalence and health-consequences of physical inactivity and summarises some of the key facts and figures on the economic costs of

More information

Informational Series. Community TM. Glossary of Health Insurance & Medical Terminology. (855) 624-6463 HealthOptions.

Informational Series. Community TM. Glossary of Health Insurance & Medical Terminology. (855) 624-6463 HealthOptions. Informational Series Glossary of Health Insurance & Medical Terminology How to use this glossary This glossary has many commonly used terms, but isn t a full list. These glossary terms and definitions

More information

Individual Health Plan Proposal

Individual Health Plan Proposal Individual Health Plan Proposal Table of Contents Page Section Ⅰ Company Introduction 3 Section Ⅱ Plan Introduction 4 Ⅰ Geographic Coverage 4 Ⅱ Benefit Schedule 4 Ⅲ Exclusions 8 Section Ⅲ Plan Administration

More information

SERVICES OFFERED: Yearly Comprehensive Medication Review (CMR) Quarterly Targeted Medication Review (TMR)

SERVICES OFFERED: Yearly Comprehensive Medication Review (CMR) Quarterly Targeted Medication Review (TMR) MEDICATION THERAPY MANAGEMENT (MTM) PROGRAM 2015 plan year This document contains information about the MTM Program for plan year 2015. Our goal is to help you get the best results from your medications

More information

Our LMMML Region. Diverse geographic and demographic landscape. Each community and stakeholder group is unique. Require unique approaches

Our LMMML Region. Diverse geographic and demographic landscape. Each community and stakeholder group is unique. Require unique approaches Engaging communities in planning local health solutions Karen Marini Consumer Engagement Manager Our LMMML Region Diverse geographic and demographic landscape Each community and stakeholder group is unique

More information

Contact: Barbara J Stout RN, BSC Implementation Specialist University of Kentucky Regional Extension Center 859-323-4895

Contact: Barbara J Stout RN, BSC Implementation Specialist University of Kentucky Regional Extension Center 859-323-4895 Contact: Barbara J Stout RN, BSC Implementation Specialist University of Kentucky Regional Extension Center 859-323-4895 $19.2B $17.2B Provider Incentives $2B HIT (HHS/ONC) Medicare & Medicaid Incentives

More information

American Maritime Officers Medical Plan Employer Identification Number: 13-5600786 Plan Number: 501 Group Number: 0081717

American Maritime Officers Medical Plan Employer Identification Number: 13-5600786 Plan Number: 501 Group Number: 0081717 AMENDMENT #4 American Maritime Officers Medical Plan Employer Identification Number: 13-5600786 Plan Number: 501 Group Number: 0081717 This Amendment is duly adopted and effective as of October 1, 2014.

More information

U.S. Contract Research Outsourcing Market: Trends, Challenges and Competition in the New Decade. N8B7-52 December 2010

U.S. Contract Research Outsourcing Market: Trends, Challenges and Competition in the New Decade. N8B7-52 December 2010 U.S. Contract Research Outsourcing Market: Trends, Challenges and Competition in the New Decade December 2010 Table of Contents Notes on Methodology 8 Market Introduction and Segmentation Introduction

More information

Coventry Health Care of Florida, Inc. Coventry Health Plan of Florida, Inc. Coventry Health and Life Insurance Company Commercial Lines of Business

Coventry Health Care of Florida, Inc. Coventry Health Plan of Florida, Inc. Coventry Health and Life Insurance Company Commercial Lines of Business Coventry Health Care of Florida, Inc. Coventry Health Plan of Florida, Inc. Coventry Health and Life Insurance Company Commercial Lines of Business Quality Management Program 2012 Overview Quality Improvement

More information

OUR COMMUNITY: OUR SERVICES... a snapshot. Working together to improve the health and wellbeing of our community

OUR COMMUNITY: OUR SERVICES... a snapshot. Working together to improve the health and wellbeing of our community OUR COMMUNITY: OUR SERVICES... a snapshot Working together to improve the health and wellbeing of our community Our Community, Our Services..a snapshot Locked Mail Bag 21 TAREN POINT NSW 2229 This work

More information

LEARN MORE AT: www.aroc.org. AROC puts DO Physicians within your reach!

LEARN MORE AT: www.aroc.org. AROC puts DO Physicians within your reach! MARKETING GUIDE LEARN MORE AT: AROC puts DO Physicians within your reach! AROC is hosted annually by the New Jersey Association of Osteopathic Physicians and Surgeons (NJAOPS). Founded in 1901, NJAOPS

More information

OBJECTIVES AGING POPULATION AGING POPULATION AGING IMPACT ON MEDICARE AGING POPULATION

OBJECTIVES AGING POPULATION AGING POPULATION AGING IMPACT ON MEDICARE AGING POPULATION OBJECTIVES Kimberly S. Hodge, PhDc, MSN, RN, ACNS-BC, CCRN- K Director, ACO Care Management & Clinical Nurse Specialist Franciscan ACO, Inc. Central Indiana Region Indianapolis, IN By the end of this session

More information

TOP 10 TRENDS IN HEALTHCARE, MEDICAL. HJ ABDUL AZIZ ABDUL RAHMAN Chief Executive Officer

TOP 10 TRENDS IN HEALTHCARE, MEDICAL. HJ ABDUL AZIZ ABDUL RAHMAN Chief Executive Officer TOP 10 TRENDS IN HEALTHCARE, MEDICAL AND PHARMACEUTICAL INDUSTRY HJ ABDUL AZIZ ABDUL RAHMAN Chief Executive Officer KPJSeremban Specialist Hospital KPJ SEREMBAN SPECIALIST HOSPITAL Presented by : Hj Abd

More information

ACT Chronic Conditions Strategy Improving Care and Support

ACT Chronic Conditions Strategy Improving Care and Support ACT Chronic Conditions Strategy Improving Care and Support 2013-2018 Foreword by Katy Gallagher The ACT Chronic Conditions Strategy 2013-18 sets a direction for the care and support of those living with

More information

Prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (AF) with one or more risk factors

Prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (AF) with one or more risk factors News Release For use outside the US and UK only Bayer Pharma AG 13342 Berlin Germany Tel. +49 30 468-1111 www.bayerpharma.com Bayer s Xarelto Approved in the EU for the Prevention of Stroke in Patients

More information

Self Care in New Zealand

Self Care in New Zealand Self Care in New Zealand A roadmap toward greater personal responsibility in managing health Prepared by the New Zealand Self Medication Industry Association. July 2009 What is Self Care? Self Care describes

More information

EXERCISE SCIENCE AND NUTRITION

EXERCISE SCIENCE AND NUTRITION EXERCISE SCIENCE AND NUTRITION BEAU GREER, PH.D., CSCS, DIRECTOR Phone: 203-396-8064 Fax: 203-365-4723 Email: greerb@sacredheart.edu Program Rationale The program offers graduate level study in exercise

More information

Aligning action with aims: Optimising the benefits of workplace wellness

Aligning action with aims: Optimising the benefits of workplace wellness Aligning action with aims: Optimising the benefits of workplace wellness Dr Michael McCoy Medibank Health Solutions Strategy & Corporate Development Health & Wellbeing September 2011 Aligning action with

More information

Telehealth Solutions Enhance Health Outcomes and Reduce Healthcare Costs

Telehealth Solutions Enhance Health Outcomes and Reduce Healthcare Costs Text for a pull out can go heretext for a pull out can go heretext for a pull out can go Text for a pull out can go here Text for a pull out can go here Telehealth Solutions Enhance Health Outcomes and

More information

SENATE COMMUNITY AFFAIRS LEGISLATION COMMITTEE

SENATE COMMUNITY AFFAIRS LEGISLATION COMMITTEE SENATE COMMUNITY AFFAIRS LEGISLATION COMMITTEE Public Hearings: ADDITIONAL ESTIMATES FOR 2012-2013 Wednesday, 13 February to Thursday, 14 February 2013 Committee Room 2S1, Parliament House, Canberra ACT

More information

Collaborative Onsite Medical Care in the Workplace

Collaborative Onsite Medical Care in the Workplace Collaborative Onsite Medical Care in the Workplace Sue Dierksen, MPH,RN, COHN-S/CM, CSP Director of Business Health- Aspirus Clinics Holly Bauer, RN BSN Health Services Supervisor, Sentry Insurance Objectives

More information

11/2/2015 Domain: Care Coordination / Patient Safety

11/2/2015 Domain: Care Coordination / Patient Safety 11/2/2015 Domain: Care Coordination / Patient Safety 2014 CT Commercial Medicaid Compared to 2012 all LOB Medicaid Quality Compass Benchmarks 2 3 4 5 6 7 8 9 10 Documentation of Current Medications in

More information

Healthcare Professional Education Services

Healthcare Professional Education Services Healthcare Professional Education Services Introducing Blackmores Institute s Educational Services More than 70 per cent of Australians now regularly take complementary medicines. As health professionals,

More information

NATIONAL HEALTHCARE AGREEMENT 2012

NATIONAL HEALTHCARE AGREEMENT 2012 NATIONAL HEALTHCARE AGREEMENT 2012 Council of Australian Governments An agreement between the Commonwealth of Australia and the States and Territories, being: t t t t t t t t the State of New South Wales;

More information

Chronic Disease and Physiotherapy

Chronic Disease and Physiotherapy Approved: 2009 Due for review: 2012 Chronic Disease and Physiotherapy Background In 2005 the Australian Health Ministers Conference published its National Chronic Disease Strategy (NCDS). The NCDS identifies

More information

Physician and other health professional services

Physician and other health professional services O n l i n e A p p e n d i x e s 4 Physician and other health professional services 4-A O n l i n e A p p e n d i x Access to physician and other health professional services 4 a1 Access to physician care

More information

MTAA KEY POLICIES FOR 2013 ELECTION. 1 February 2013. 1. Improving reimbursement of medical technologies by private health insurance

MTAA KEY POLICIES FOR 2013 ELECTION. 1 February 2013. 1. Improving reimbursement of medical technologies by private health insurance MTAA KEY POLICIES FOR 2013 ELECTION 1 February 2013 1. Improving reimbursement of medical technologies by private health insurance Medical technology is not funded by the Commonwealth Government in the

More information

Midwest ESOP Conference. September 11, 2015

Midwest ESOP Conference. September 11, 2015 Midwest ESOP Conference September 11, 2015 Why are you here today? I want to fix my company s healthcare problem Rising healthcare costs are: Negatively affecting my bottom line, EBITDA, stock price, etc

More information

UnitedHealthcare Choice Plus. UnitedHealthcare Insurance Company. Certificate of Coverage

UnitedHealthcare Choice Plus. UnitedHealthcare Insurance Company. Certificate of Coverage UnitedHealthcare Choice Plus UnitedHealthcare Insurance Company Certificate of Coverage For the Plan 7EG of Educators Benefit Services, Inc. Enrolling Group Number: 717578 Effective Date: January 1, 2012

More information

UnitedHealthcare Choice Plus. UnitedHealthcare Insurance Company. Certificate of Coverage

UnitedHealthcare Choice Plus. UnitedHealthcare Insurance Company. Certificate of Coverage UnitedHealthcare Choice Plus UnitedHealthcare Insurance Company Certificate of Coverage For the Health Savings Account (HSA) Plan 7PD of Educators Benefit Services, Inc. Enrolling Group Number: 717578

More information

Persistence Market Research

Persistence Market Research Persistence Market Research Global Obesity Surgery Devices Market Will Reach $2,489.5 Million in 2020 - Persistence Market Research Persistence Market Research 1 Persistence Market Research Released New

More information

MULTIPLE SCLEROSIS AUSTRALIA MULTIPLE SCLEROSIS RESEARCH AUSTRALIA

MULTIPLE SCLEROSIS AUSTRALIA MULTIPLE SCLEROSIS RESEARCH AUSTRALIA MULTIPLE SCLEROSIS AUSTRALIA MULTIPLE SCLEROSIS RESEARCH AUSTRALIA Submission to the ACT Legislative Assembly Health, Ageing, Community and Social Services Inquiry into the exposure draft of the Drugs

More information

5/5/2015 PHARMACY WHAT S AN EMPLOYER TO DO? Current Structure Misaligned

5/5/2015 PHARMACY WHAT S AN EMPLOYER TO DO? Current Structure Misaligned PHARMACY WHAT S AN EMPLOYER TO DO? MAY 15, 2015 Debbie Doolittle Nashville, TN Pharmaceutical Spending Per Capita, 2013 vs. 2018 The US vs. the Rest of the World 1 Current Pharmacy Landscape How Did We

More information

Disclosure Information and Summary of Benefits for the Basic Medicare Supplement Plan

Disclosure Information and Summary of Benefits for the Basic Medicare Supplement Plan Disclosure Information and Summary of Benefits for the Basic Medicare Supplement Plan From the Minnesota Comprehensive Health Association (MCHA) PO Box 9310 Minneapolis, Minnesota 55440-9310 Beginning

More information

Type 1 Diabetes ( Juvenile Diabetes)

Type 1 Diabetes ( Juvenile Diabetes) Type 1 Diabetes W ( Juvenile Diabetes) hat is Type 1 Diabetes? Type 1 diabetes, also known as juvenile-onset diabetes, is one of the three main forms of diabetes affecting millions of people worldwide.

More information

Knowledge Synergies The New Paradigm of Innovation. Israel Makov

Knowledge Synergies The New Paradigm of Innovation. Israel Makov Knowledge Synergies The New Paradigm of Innovation Israel Makov New England-Israel Life Sciences Summit - October 26, 2009 Pharma Industry Challenges and Pressures At an All-Time High Historically Low

More information

Public Hospital. Bronze Extras * Ambulance cover

Public Hospital. Bronze Extras * Ambulance cover Effective 1 July 2015 Hospital & Bronze Extras * *This cover is closed to new members Our Hospital & Bronze Extras cover gives you cover as a private patient in a public hospital for most services, as

More information

Conducting Clinical Trials in Turkey

Conducting Clinical Trials in Turkey Conducting Clinical Trials in Turkey A Resource for Sponsors Prepared by: Ömer Sadun Okyaltırık Pharm-Olam Turkey Country & Clinical Operations Manager Yamin Mo Khan Pharm-Olam International, Executive

More information

Report to the Australian Senate on anti-competitive and other practices by health funds and providers in relation to private health insurance

Report to the Australian Senate on anti-competitive and other practices by health funds and providers in relation to private health insurance 5 September 2011 Louise Macleod Director Intelligence, Infocentre and Policy Liaison Branch Australian Competition and Consumer Commission GPO Box 3131 Canberra ACT 2601 By email: phireport@accc.gov.au

More information

CREATING A POPULATION HEALTH PLAN FOR VIRGINIA

CREATING A POPULATION HEALTH PLAN FOR VIRGINIA CREATING A POPULATION HEALTH PLAN FOR VIRGINIA Life Expectancy 1900, 2013 1900 50.6 years old 2013 78.8 years old 0 20 40 60 80 100 Age (Years) Source: http://ucatlas.ucsc.edu/health.php Year - 2000 Source:

More information

Disease Management Identifications and Stratification Health Risk Assessment Level 1: Level 2: Level 3: Stratification

Disease Management Identifications and Stratification Health Risk Assessment Level 1: Level 2: Level 3: Stratification Disease Management UnitedHealthcare Disease Management (DM) programs are part of our innovative Care Management Program. Our Disease Management (DM) program is guided by the principles of the UnitedHealthcare

More information

Maharashtra University of Health Sciences, Nashik

Maharashtra University of Health Sciences, Nashik Additional List of for Academic Year 2011-12 under the Master of Physiotherapy (Post Graduate) Master of Physiotherapy in Cardiovascular & Respiratory Sciences 1 The effect of six weeks of walking training

More information

Market Access for Medical Technology & Pharmaceutical Companies An Organizational Priority in Times of Economic Austerity and Reform

Market Access for Medical Technology & Pharmaceutical Companies An Organizational Priority in Times of Economic Austerity and Reform Market Access for Medical Technology & Pharmaceutical Companies An Organizational Priority in Times of Economic Austerity and Reform By Joakim Steen Mikkelsen, Managing Healthcare Counselor, Embassy of

More information

The majority of pharmaceutical companies in

The majority of pharmaceutical companies in Pharmaceutical Infrastructure and Industry Professor Che-Ming Teng, Ph.D. National Taiwan University College of Medicine, Taipei, Taiwan The majority of pharmaceutical companies in Taiwan are devoted to

More information

Medicare At A Glance. State Health Insurance Assistance Program (SHIP)

Medicare At A Glance. State Health Insurance Assistance Program (SHIP) 2015 Medicare At A Glance Indiana 2015 State Health Insurance Assistance Program (SHIP) Who runs the Medicare Program? The Centers for Medicare & Medicaid Services (CMS) is the Federal agency that runs

More information

If you have a question about whether MedStar Family Choice covers certain health care, call MedStar Family Choice Member Services at 888-404-3549.

If you have a question about whether MedStar Family Choice covers certain health care, call MedStar Family Choice Member Services at 888-404-3549. Your Health Benefits Health services covered by MedStar Family Choice The list below shows the healthcare services and benefits for all MedStar Family Choice members. For some benefits, you have to be

More information

Member s responsibility (deductibles, copays, coinsurance and dollar maximums)

Member s responsibility (deductibles, copays, coinsurance and dollar maximums) MICHIGAN CATHOLIC CONFERENCE January 2015 Benefit Summary This is intended as an easy-to-read summary and provides only a general overview of your benefits. It is not a contract. Additional limitations

More information

The Centers for Medicare & Medicaid Services (CMS) strives to make information available to all. Nevertheless, portions of our files including

The Centers for Medicare & Medicaid Services (CMS) strives to make information available to all. Nevertheless, portions of our files including The Centers for Medicare & Medicaid Services (CMS) strives to make information available to all. Nevertheless, portions of our files including charts, tables, and graphics may be difficult to read using

More information